APA

Gelmon K. A., Cristofanilli M., Rugo H. S., DeMichele A. M., Joy A. A., Castrellon A., Sleckman B., Mori A., Theall K. P., Lu D. R., Huang X., Bananis E., Finn R. S. & Slamon D. J. (20210617). Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. : The breast journal.

Chicago

Gelmon Karen A, Cristofanilli Massimo, Rugo Hope S, DeMichele Angela M, Joy Anil A, Castrellon Aurelio, Sleckman Bethany, Mori Ave, Theall Kathy Puyana, Lu Dongrui R, Huang Xin, Bananis Eustratios, Finn Richard S and Slamon Dennis J. 20210617. Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. : The breast journal.

Harvard

Gelmon K. A., Cristofanilli M., Rugo H. S., DeMichele A. M., Joy A. A., Castrellon A., Sleckman B., Mori A., Theall K. P., Lu D. R., Huang X., Bananis E., Finn R. S. and Slamon D. J. (20210617). Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. : The breast journal.

MLA

Gelmon Karen A, Cristofanilli Massimo, Rugo Hope S, DeMichele Angela M, Joy Anil A, Castrellon Aurelio, Sleckman Bethany, Mori Ave, Theall Kathy Puyana, Lu Dongrui R, Huang Xin, Bananis Eustratios, Finn Richard S and Slamon Dennis J. Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. : The breast journal. 20210617.